Congress trades

Bruker Corporation (BRKR)

NASDAQ · Healthcare · 13 congress trades · last filed 3 years ago

13
Congress disclosures shown
31d
Median delay on the congress disclosures
of the 45 day limit
6/7
Purchases and sales in the disclosures shown

About Bruker Corporation

from the company's filings and listing
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical - Devices
Chief executive
Frank H. Laukien
Employees
11,085
Listed since
Aug 4, 2000
Market value
$8.3B
Price to earnings
-
Earnings per share
-$0.47
Dividend yield
0.37%

www.bruker.com

Earnings

6 reported quarters · next on Nov 2, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Aug 4, 2026$0.49$0.38$838.5M$853.6MEPS beatRevenue miss
Q1 FY2026reported May 6, 2026$0.31$0.23$823.4M$795.6MEPS beatRevenue beat
Feb 12, 2026$0.59$0.65$977.2M$962.3MEPS missRevenue beat
Q3 FY2025reported Nov 3, 2025$0.60$0.33$860.5M$964.6MEPS beatRevenue miss
Q2 FY2025reported Aug 4, 2025$0.32$0.33$797.4M$810.2MEPS missRevenue miss
Q1 FY2025reported May 7, 2025$0.47$0.46$801.4M$819.9MEPS beatRevenue miss

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2025 · proxy filed Apr 10, 2026
ExecutiveSalaryStock awardsOtherTotal
Frank H. Laukien, Ph.D.Chairman, President and Chief Executive Officer$977K$1.6M$2.1M$4.7M
Mark R. Munch, Ph.D.Executive Vice President & President, Bruker NANO Grou$738K$792K$648K$2.2M
Gerald N. HermanExecutive Vice President and Chief Financial Officer$644K$866K$500K$2.0M
Juergen W. SregaPresident, Bruker CALID Group$504K$488K$431K$1.4M
Falko Busse, Ph.D.President, Bruker BioSpin Group$545K$311K$565K$1.4M

The summary compensation table from the 2025 proxy statement, current executives only. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
FMR LLC$1.2B20,237,425+25.7%13.30%
Orbis Allan Gray Ltd$1.1B17,940,0760.0%11.79%
Blackrock, Inc.$686.5M11,407,332+2.0%7.50%
Pallas Capital Advisors LLC$570.7M9,483,978+0.0%6.23%
Vanguard Portfolio Management LLC$294.2M4,888,290+0.7%3.21%
Vanguard Capital Management LLC$292.4M4,859,252+0.9%3.19%
Sculptor Capital LP$278.3M4,625,000+41.4%3.04%
State Street Corp$241.9M4,017,673+2.8%2.64%
Franklin Resources Inc$194.3M3,229,337+10.6%2.12%
Sachem Head Capital Management LP$175.4M2,915,000+100.0%1.92%
Edmond De Rothschild Holding S.A.$169.9M2,823,178-15.9%1.85%
Dimensional Fund Advisors LP$157.1M2,610,051+11.5%1.71%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next BRKR filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in BRKR

13 disclosures of 13 on record · median 31d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Ro KhannaStockSale$1,001 - $15,000-20.2%S&P +85.1% · vs S&P 500 -105.2%May 23, 2023Jun 12, 202320d
Ro KhannaStockPurchase$1,001 - $15,000-1.2%S&P +91.9% · vs S&P 500 -93.2%May 10, 2022Jun 10, 202231d
Michael T. McCaulStockSale$15,001 - $50,000-20.1%S&P +81.6% · vs S&P 500 -101.7%Jun 2, 2021Jul 16, 202144d
Michael T. McCaulStockSale$15,001 - $50,000-21.2%S&P +84.0% · vs S&P 500 -105.3%May 21, 2021Jun 17, 202127d
Michael T. McCaulStockSale$1,001 - $15,000-21.4%S&P +82.2% · vs S&P 500 -103.6%May 26, 2021Jun 17, 202122d
Michael T. McCaulStockSale$15,001 - $50,000-21.4%S&P +82.2% · vs S&P 500 -103.6%May 26, 2021Jun 17, 202122d
Michael T. McCaulStockSale$15,001 - $50,000-18.1%S&P +88.3% · vs S&P 500 -106.5%May 12, 2021Jun 17, 202136d
Michael T. McCaulStockPurchase$1,001 - $15,000+1.5%S&P +109.5% · vs S&P 500 -108.0%Dec 14, 2020Jan 25, 202142d
Michael T. McCaulFiled lateStockPurchase$15,001 - $50,000+61.9%S&P +203.3% · vs S&P 500 -141.4%Apr 2, 2020May 18, 202046d
Michael T. McCaulFiled lateStockPurchase$50,001 - $100,000+61.9%S&P +203.3% · vs S&P 500 -141.4%Apr 2, 2020May 18, 202046d
Ro KhannaStockSale$1,001 - $15,000+48.7%S&P +169.0% · vs S&P 500 -120.3%Apr 14, 2020May 13, 202029d
Ro KhannaStockPurchase$1,001 - $15,000+42.2%S&P +160.2% · vs S&P 500 -117.9%Apr 29, 2019May 10, 201911d
Michael T. McCaulStockPurchase$1,001 - $15,000+99.8%S&P +271.7% · vs S&P 500 -171.9%May 9, 2016Jun 16, 201638d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 9, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Questions

Which members of Congress have traded BRKR?

Ro Khanna, Michael T. McCaul disclosed BRKR transactions in the filings shown here.

How quickly are BRKR trades disclosed?

Congressional disclosures took a median of 31 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days late, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track